HD-tDCS for Hallucinations

NANot yet recruitingINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

February 28, 2024

Primary Completion Date

February 28, 2028

Study Completion Date

July 30, 2028

Conditions
SchizophreniaHallucinations
Interventions
PROCEDURE

High-definition transcranial direct current (HD-tDCS), active condition

Patients will receive 20 sessions of active HD-tDCS for a duration of 20min. Sessions will be delivered twice-daily over 2 weeks on the 5 consecutive working days. The number of electrodes used, electrode placement on the scalp (based on EEG 10/10), and the individual currents that need to be injected from each electrode will be determined based on the brain networks identified as involved in their hallucinations during a fMRI acquisition performed at baseline, and computed using a neurotargeting software that allows determining optimal electrode montages for achieving maximal brain current flow in the targeted brain region.

PROCEDURE

High-definition transcranial direct current (HD-tDCS), sham condition

Participants will receive 20 sessions of sham HD-tDCS, which will be delivered following the same procedures as active HD-tDCS. However, stimulation will only be administered in the initial 30 seconds of the 20-minute period, with no further stimulation during the remaining duration. This approach aims to replicate the tingling sensation commonly associated with active stimulation.

Trial Locations (1)

69678

Centre Hospitalier le Vinatier, Bron

All Listed Sponsors
lead

Hôpital le Vinatier

OTHER

NCT06208176 - HD-tDCS for Hallucinations | Biotech Hunter | Biotech Hunter